Essential role of platelet-activating factor in male reproduction: a review

被引:6
|
作者
Ali, Atef
Kattygnarath, Tiao Virirak
Benkhalifa, Moncef
Miron, Pierre [1 ]
机构
[1] Ctr Fertil & Reprod FERTILYS, Laval, PQ, Canada
[2] Univ Montreal, Fac Med, Hop Maison Neuve Rosemont, Dept Obstet & Gynecol, Montreal, PQ, Canada
[3] ATL R&D Lab, F-78320 La Verriere, France
关键词
acrosome reaction; capacitation; PAF; platelet-activating factor; sperm function; sperm motility;
D O I
10.1016/S1472-6483(10)60795-X
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
The use of pharmacological adjuvants to enhance sperm function is a real possibility and a very attractive proposition. However, the role of such adjuvants must be well defined to maximize therapeutic outcome for specific patient populations. Platelet-activating factor (PAF) is a potent signalling phospholipid that has been implicated in a number of biological activities. In the field of reproductive biology, PAF has been shown to have an important role in ovulation, sperm function, embryo implantation, fetal lung maturation, and initiation and maintenance of parturition. Although the exact mechanisms are not clear, it has been demonstrated in several species that PAF can influence sperm function by affecting the motility, capacitation, acrosome reaction and fertility of spermatozoa. The reproductive significance of PAF activity in spermatozoa and fertilization and its role in the establishment of pregnancy requires further study. Understanding the role of PAF in a reproductive process, such as in intrauterine insemination, could eventually lead researchers to explore its role in more complex reproductive technologies. This review summarizes the current research on the significant role of PAF in male mammalian reproductive functions, as well as its possible application in some assisted reproductive technologies.
引用
收藏
页码:250 / 255
页数:6
相关论文
共 50 条
  • [41] Role of platelet-activating factor in pathogenesis of acute pancreatitis
    Li-Rong Liu Shi-Hai Xia Department of Gastroenterology
    World Journal of Gastroenterology, 2006, (04) : 539 - 545
  • [42] The role of platelet-activating factor in the haemoincompatibility of haemodialytic treatments
    Tetta, C
    Wratten, M
    Cristol, JP
    Tarchini, R
    Bosc, JY
    Canaud, B
    Camussi, G
    INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 1998, 21 (11): : 693 - 698
  • [43] THE POTENTIAL ROLE OF PLATELET-ACTIVATING FACTOR IN SHOCK AND ISCHEMIA
    HOSFORD, D
    BRAQUET, P
    JOURNAL OF CRITICAL CARE, 1990, 5 (02) : 115 - 136
  • [44] Is there a role of platelet-activating factor in human lung cancer?
    Denizot, Y
    Desplat, V
    Drouet, M
    Bertin, F
    Melloni, B
    LUNG CANCER, 2001, 33 (2-3) : 195 - 202
  • [45] The role of platelet-activating factor in the biocompatibility of hemodialysis membranes
    Tetta, C
    HaeffnerCavaillon, N
    Navino, C
    David, S
    Franceschi, C
    Mariano, F
    Camussi, G
    PLATELET-ACTIVATING FACTOR AND RELATED LIPID MEDIATORS 2: ROLES IN HEALTH AND DISEASE, 1996, 416 : 243 - 248
  • [46] Mediterranean diet and platelet-activating factor; a systematic review
    Nomikos, Tzortzis
    Fragopoulou, Elizabeth
    Antonopoulou, Smaragdi
    Panagiotakos, Demosthenes B.
    CLINICAL BIOCHEMISTRY, 2018, 60 : 1 - 10
  • [47] PLATELET-ACTIVATING FACTOR AND ASTHMA
    BARNES, PJ
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1988, 81 (01) : 152 - 160
  • [48] Platelet-Activating Factor and Pain
    Tsuda, Makoto
    Tozaki-Saitoh, Hidetoshi
    Inoue, Kazuhide
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2011, 34 (08) : 1159 - 1162
  • [49] Platelet-activating factor acetylhydrolase
    Arai, H
    PROSTAGLANDINS & OTHER LIPID MEDIATORS, 2002, 68-9 : 83 - 94
  • [50] NEPHROPATHIES AND PLATELET-ACTIVATING FACTOR
    PIROTZKY, E
    COLLIEZ, P
    GUILMARD, C
    BRAQUET, P
    PEDIATRIE, 1989, 44 (03): : 163 - 167